According to Diodes Inc., its AP74502Q and AP74502HQ automotive-compliant, 80-V ideal-diode controllers provide robust, reliable protection against reverse connections and voltage transients. These ...

The Andhra Pradesh State Council of Higher Education (APSCHE) has released the AP EAMCET 2025 phase 3 and final seat allotment results at eapcet-sche.aptonline.in. Candidates must download their ...

CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

Investing.com -- Cidara Therapeutics Inc (NASDAQ:CDTX) stock surged 13.7% following the company’s announcement of updates to its planned Phase 3 registrational trial for CD388 after an End-of-Phase 2 ...

Google's Gemini AI app has been topping the "most downloaded" charts on both the Apple App Store and the Android Store ever since the company added a free image generation feature, called "Nano Banana ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Carisma Therapeutics had already laid off 95% of its team earlier this year. Now, a Hail Mary merger proposal with another biotech has fallen through. The cell therapy macrophage biotech had just six ...

TPAO has awarded additional contracts for additional development of Sakarya gas field in the Black Sea. Phase 3 involves a new floating production unit, 27 wells, and a 183-km export pipeline ...

Sept 29 (Reuters) - OpenAI is planning to release a new version of its Sora generator that creates videos featuring copyrighted material, unless rights holders opt out of having their work appear, the ...

Pre-diabetes is a condition that indicates that blood sugar levels exceed normal ranges, but have not reached diabetic levels. The condition of pre-diabetes is considered a warning sign, or precursor ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with short ...